Music Therapy in Obsessive Compulsive Disorder

NCT02314195 | Completed

• 1 other identifier: 2172719
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

Previous studies have highlighted the potential therapeutic benefits of receptive individual music therapy as an adjunct to standard care, in a variety of psychiatric ailments including mood and anxiety disorders. However, the role of music in the treatment of obsessive compulsive disorder have not been investigated to date. The present study therefore aimed to investigate the efficacy of music therapy as an adjunct to standard treatment, on obsessions in patients with treatment-naïve OCD. Moreover, given the fact that a significant proportion of patients with OCD have other comorbid mood or anxiety disorders, the question of whether therapeutic benefits of music could be expanded to also affect concurrent depressive and anxiety symptoms was explored.

Conditions

Obsessive-Compulsive Disorder; Anxiety; Depression

Keywords

Obsessive Compulsive Disorder; Music Therapy/methods; Combined Modality Therapy; Anxiety Disorders/therapy

Outcome Measures

Primary Outcomes (1)

• Obsession (Maudsley Obsessive-Compulsive Inventory)

  Post-intervention scores on Maudsley Obsessive-Compulsive Inventory

  1 month

Secondary Outcomes (3)

• Obsession subtype (Maudsley Obsessive-Compulsive Inventory sub-types)

  1 month

• Anxiety symptoms (Beck Anxiety Inventory)

  1 month

• Depressive symptoms (Beck Depression Inventory - Short Form)

  1 month

Study Arms (2)

Standard treatment + music therapy

ACTIVE COMPARATOR

Selective serotonin re-uptake inhibitor plus cognitive behavioral therapy. Music therapy encompassing 12 half-hour sessions of therapist-supervised receptive music therapy scheduled over four weeks

Drug: Selective serotonin re-uptake inhibitor; Behavioral: Cognitive Behavioral Therapy; Other: Music therapy

Standard treatment only

ACTIVE COMPARATOR

Selective serotonin re-uptake inhibitor plus cognitive behavioral therapy.

Drug: Selective serotonin re-uptake inhibitor; Behavioral: Cognitive Behavioral Therapy

Interventions

Selective serotonin re-uptake inhibitor DRUG

A medication of selective serotonin re-uptake inhibitor (SSRI) family, Behavioral. The type and dosage of the medication was decided by the treating psychiatrist.

Also known as: Pharmacotherapy

Standard treatment + music therapy; Standard treatment only

Cognitive Behavioral Therapy BEHAVIORAL

Cognitive Behavioral Therapy for obsessive compulsive disorder carried out by a psychologist.

Also known as: Psychotherapy

Standard treatment + music therapy; Standard treatment only

Music therapy OTHER

12 sessions of 30-minute individual-based receptive music therapy, supervised by the treating psychiatrist.

Also known as: Receptive music therapy

Standard treatment + music therapy

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• were at least 18 years or older;
• had axis I diagnosis of OCD according to the criteria delineated by the diagnostic and statistical manual of mental disorders - fourth edition diagnosed by an experienced psychiatrist
• had not received treatment previously for the disorder
• agreed to partake in the study

You may not qualify if:

• refused to partake in the study

Sponsors & Collaborators

• Islamic Azad University, Marvdasht: lead

Study Sites (1)

Shariati Hospital

Isfahan, Isfahan, 56465201, Iran

Location

MeSH Terms

Conditions

Obsessive-Compulsive Disorder; Anxiety Disorders; Depression

Interventions

Selective Serotonin Reuptake Inhibitors; Drug Therapy; Cognitive Behavioral Therapy; Psychotherapy; Music Therapy

Condition Hierarchy (Ancestors)

Mental Disorders; Behavioral Symptoms; Behavior

Intervention Hierarchy (Ancestors)

Neurotransmitter Uptake Inhibitors; Membrane Transport Modulators; Molecular Mechanisms of Pharmacological Action; Pharmacologic Actions; Chemical Actions and Uses; Neurotransmitter Agents; Serotonin Agents; Physiological Effects of Drugs; Therapeutics; Behavior Therapy; Behavioral Disciplines and Activities; Sensory Art Therapies; Complementary Therapies; Rehabilitation; Aftercare; Continuity of Patient Care; Patient Care

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Shahrzad Shirani Bidabadi, M.S.c

Study Record Dates

• First Submitted: November 27, 2014
• First Posted: December 11, 2014
• Study Start: April 1, 2014
• Primary Completion: June 1, 2014
• Study Completion: August 1, 2014
• Last Updated: December 11, 2014

Record last verified: 2014-12

Locations

IR (1)